Liling Warren is Head, Senior Director of Translational Medicine Statistics at Teva Pharmaceuticals. She is responsible for building and applying computational biology, ML/AI, statistical genetics, biomarker analytics to support drug discovery and development projects at Teva. She served as a member of the scientific committee in GRC (Genomic Research Consortium) to evaluate and assess drug discovery and drug repurposing opportunities using Real World Data (RWD)-based GWAS and PheWAS studies. Before joining Teva, she was Head of US biostatistics at Acclarogen and led several large-scale pharmacogenetic and human genetics projects at GSK. She received her Ph.D. in Bioinformatics and MS in Statistics from North Carolina State University.